XYRALID
Innovus Pharmaceuticals, Inc.
Application Filed: 2017-03-09
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87365716 |
| Registration Number | 5397912 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Randy Berholtz |
| Law Office Assigned | L20 |
| Employee Name | GARTNER, JOHN M |
Timeline
| 2017-03-09 | Application Filed |
| 2017-07-11 | Published for Opposition |
| 2017-11-29 | Date of First Use |
| 2018-02-06 | Status: Live/Registered |
| 2018-02-06 | Trademark Registered |
| 2018-11-09 | Location: POST REGISTRATION |
| 2019-11-07 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Innovus Pharmaceuticals, Inc. |
| Address | 8845 Rehco Road San Diego CA 92121 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| A00001 | In the statement, after "Topical anesthetics" "; all of the foregoing excluding Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in the treatment and/or management of sleep disorders, neurological disorders" is inserted. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-03-13 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-03-15 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-05-31 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-05-31 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-06-21 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-07-11 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-07-11 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-09-05 | 8 NOAM E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2017-11-08 | 9 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2017-11-08 | 10 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2017-11-08 | 11 CHAN I:Incoming Correspondence |
| TEAS STATEMENT OF USE RECEIVED | 2017-12-08 | 12 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2017-12-21 | 13 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2017-12-08 | 14 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2017-12-21 | 15 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2018-01-02 | 16 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2018-01-03 | 17 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2018-02-06 | 18 R.PR A:Allowance for Publication |
| TEAS SECTION 7 REQUEST RECEIVED | 2018-10-09 | 19 ES7R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2018-11-09 | 20 APRE A:Allowance for Publication |
| AMENDMENT UNDER SECTION 7 - ISSUED | 2018-11-09 | 21 A7OK O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-12-20 | 22 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-12-20 | 23 ARAA I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-11-06 | 24 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-11-06 | 25 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-05-14 | 26 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-05-14 | 27 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-05-14 | 28 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2020-05-14 | 29 EWAF I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-05-14 | 30 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-05-14 | 31 CHAN I:Incoming Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | 2020-06-17 | 32 CORV 1: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-10-06 | 33 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-10-06 | 34 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-10-06 | 35 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-10-06 | 36 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-10-06 | 37 CHAN I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-03-26 | 38 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-03-26 | 39 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-03-26 | 40 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-03-26 | 41 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-03-26 | 42 CHAN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-02-06 | 43 REM1 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-10-10 | 44 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-10-10 | 45 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-10-10 | 46 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-10-10 | 47 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-10-10 | 48 TCCA I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 XYRALID 87365716 5397912 Live/Registered |
Innovus Pharmaceuticals, Inc. 2017-03-09 |
 XYRALID 86023287 not registered Dead/Abandoned |
Innovus Pharmaceuticals, Inc. 2013-07-30 |
 XYRALID 77049293 not registered Dead/Abandoned |
Auriga Laboratories, Inc. 2006-11-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 